Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:physicians [12.18.2018] – [Resources for physicians] sallieqhome:physicians [12.18.2018] – [Resources for physicians] sallieq
Line 6: Line 6:
 The Marshall Protocol (MP) is the name given to a therapy devised by Professor Trevor Marshall. Based on the pathogenesis Marshall has proposed for chronic inflammatory disease, the MP is aimed at targeting bacteria, fungi, viruses, and other microbes that appear to interact to cause chronic inflammatory diseases. The Marshall Protocol (MP) is the name given to a therapy devised by Professor Trevor Marshall. Based on the pathogenesis Marshall has proposed for chronic inflammatory disease, the MP is aimed at targeting bacteria, fungi, viruses, and other microbes that appear to interact to cause chronic inflammatory diseases.
  
-Marshall (and colleagueshave hypothesized that chronic inflammatory diseases, including many autoimmune diseases, are caused by dysbiosis of a metagenomic microbiota: communities of microbial pathogens, many of which persist intracellularly. A [[home:publications:proal_autoimmunity_reviews_2009|recent (2009) peer-reviewed paper]] describes this [[home:pathogenesis|Pathogenesis]] in more detail.(({{pubmed>long:19393196}})) +Marshall and colleagues have hypothesized that chronic inflammatory diseases, including many autoimmune diseases, are caused by dysbiosis of a metagenomic microbiota: communities of microbial pathogens, many of which persist intracellularly. A [[home:publications:proal_autoimmunity_reviews_2009|recent (2009) peer-reviewed paper]] describes this [[home:pathogenesis|Pathogenesis]] in more detail.(({{pubmed>long:19393196}})) 
  
 Supported by Autoimmunity Research Foundation, the MP has been available since 2002 and has [[home:publications:perez_congress_on_autoimmunity_2008|been used]] in a wide range of chronic inflammatory illnesses.   Supported by Autoimmunity Research Foundation, the MP has been available since 2002 and has [[home:publications:perez_congress_on_autoimmunity_2008|been used]] in a wide range of chronic inflammatory illnesses.  
home/physicians.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.